J. Todd

发表

Fusion peptide priming reduces immune responses to HIV-1 envelope trimer base

J. Mascola, R. Koup, Baoshan Zhang, 2021, Cell reports.

Structure-Based Design of a Fusion Glycoprotein Vaccine for Respiratory Syncytial Virus

Cinque S. Soto, U. Baxa, G. Chuang, 2013, Science.

Protection against malaria at 1 year and immune correlates following PfSPZ vaccination

Mario Roederer, Sumana Chakravarty, Martha C Nason, 2016, Nature Medicine.

Antibody Lineages with Vaccine-Induced Antigen-Binding Hotspots Develop Broad HIV Neutralization

J. Mullikin, J. Mascola, Yicheng Guo, 2019, Cell.

Potent anti-viral activity of a trispecific HIV neutralizing antibody in SHIV-infected monkeys.

J. Mascola, R. Koup, J. Lifson, 2022, Cell reports.

Activation and lysis of human CD4 cells latently infected with HIV-1

J. Mascola, R. Koup, J. Casazza, 2015, Nature Communications.

Trispecific broadly neutralizing HIV antibodies mediate potent SHIV protection in macaques

Mario Roederer, Tongqing Zhou, Gary J. Nabel, 2017, Science.

Surface-Matrix Screening Identifies Semi-specific Interactions that Improve Potency of a Near Pan-reactive HIV-1-Neutralizing Antibody

J. Mascola, E. Reinherz, G. Chuang, 2018, Cell reports.

Sustained Delivery of a Broadly Neutralizing Antibody in Nonhuman Primates Confers Long-Term Protection against Simian/Human Immunodeficiency Virus Infection

J. Mascola, A. Haase, G. Nabel, 2015, Journal of Virology.

Quantification of the Impact of the HIV-1-Glycan Shield on Antibody Elicitation.

Cinque S. Soto, B. Haynes, J. Mascola, 2017, Cell reports.

Amarendra Pegu than those to the CD 4 receptor Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo

J. Hoxie, J. Mascola, M. Connors, 2014 .

Evaluation of candidate vaccine approaches for MERS-CoV

Ulas Bagci, Tongqing Zhou, Yi Zhang, 2015, Nature Communications.

Rapid development of a DNA vaccine for Zika virus

J. Mascola, T. Pierson, S. Higgs, 2016, Science.

Antibody Lineages with Vaccine-Induced Antigen-Binding Hotspots Develop Broad HIV Neutralization

J. Mullikin, J. Mascola, Yicheng Guo, 2019, Cell.

Development of an In Vivo Probe to Track SARS-CoV-2 Infection in Rhesus Macaques

E. L. Potter, S. Chanda, T. Hope, 2021, Frontiers in Immunology.

Efficacy and safety of five injectable anesthetic regimens for chronic blood collection from the anterior vena cava of Guinea pigs.

J. Todd, Srinivas S. Rao, L. Detolla, 2008, Journal of the American Association for Laboratory Animal Science : JAALAS.

Interprotomer disulfide-stabilized variants of the human metapneumovirus fusion glycoprotein induce high titer-neutralizing responses

J. Mascola, G. Chuang, M. Sastry, 2021, Proceedings of the National Academy of Sciences.

Vectored delivery of anti-SIV envelope targeting mAb via AAV8 protects rhesus macaques from repeated limiting dose intrarectal swarm SIVsmE660 challenge

J. Mascola, J. Lifson, G. Alter, 2018, PLoS pathogens.

Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in nonhuman primates is coincident with an anamnestic antibody response in the lower airway

J. Mascola, E. Boritz, D. Douek, 2021, bioRxiv.

Correction: Corrigendum: Protection against malaria at 1 year and immune correlates following PfSPZ vaccination

Andrea A. Berry, S. Hoffman, S. Kappe, 2016, Nature Medicine.

Anti-viral efficacy of a next-generation CD4-binding site bNAb in SHIV-infected animals in the absence of anti-drug antibody responses

J. Mascola, R. Koup, E. Yang, 2022, iScience.

DNA Vaccination Elicits Protective Immune Responses against Pandemic and Classic Swine Influenza Viruses in Pigs

A. Vincent, G. Nabel, W. Kong, 2011, Clinical and Vaccine Immunology.

Swine Influenza Viruses in Pigs 2

G. Nabel, W. Kong, J. Todd, 2011 .

Concordance of immunological events between intrarectal and intravenous SHIVAD8-EO infection when assessed by Fiebig-equivalent staging.

J. Mascola, R. Koup, J. Lifson, 2021, The Journal of clinical investigation.

Investigation of the impact of clonal hematopoiesis on severity and pathophysiology of COVID-19 in rhesus macaques

D. Douek, Mark G. Lewis, M. Roederer, 2023, bioRxiv.

Evaluation of the mRNA-1273 Vaccine against SARS-CoV-2 in Nonhuman Primates

J. Mascola, R. Baric, N. Sullivan, 2020, The New England journal of medicine.

Immune correlates of protection by mRNA-1273 vaccine against SARS-CoV-2 in nonhuman primates

J. Mascola, D. Montefiori, D. Douek, 2021, Science.

Bispecific Antibodies Targeting Different Epitopes on the HIV-1 Envelope Exhibit Broad and Potent Neutralization

W. Shi, J. Mascola, G. Chuang, 2015, Journal of Virology.

Rational Design of an Epstein-Barr Virus Vaccine Targeting the Receptor-Binding Site

U. Baxa, J. Mascola, M. Rossmann, 2015, Cell.

Gene-Based Vaccination with a Mismatched Envelope Protects against Simian Immunodeficiency Virus Infection in Nonhuman Primates

J. Mascola, N. Letvin, G. Nabel, 2012, Journal of Virology.

Type I interferon responses in rhesus macaques prevent SIV infection and slow disease progression

E. Boritz, J. Lifson, D. Douek, 2014, Nature.

Structure-based design of a quadrivalent fusion glycoprotein vaccine for human parainfluenza virus types 1–4

M. Beltramello, U. Baxa, J. Mascola, 2018, Proceedings of the National Academy of Sciences.

Broadly Neutralizing Human Immunodeficiency Virus Type 1 Antibody Gene Transfer Protects Nonhuman Primates from Mucosal Simian-Human Immunodeficiency Virus Infection

J. Mascola, D. Baltimore, A. Haase, 2015, Journal of Virology.

Neutralizing Human Immunodeficiency Virus Type 1 Antibody Gene Transfer Protects Nonhuman Primates from Mucosal Simian-Human Immunodeficiency Virus Infection

J. Mascola, D. Baltimore, A. Haase, 2015 .

Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates

B. Haynes, D. Douek, N. Sullivan, 2021, Science Translational Medicine.

Vaccination with SARS-CoV-2 Spike Protein and AS03 Adjuvant Induces Rapid Anamnestic Antibodies in the Lung and Protects Against Virus Challenge in Nonhuman Primates

B. Haynes, D. Douek, N. Sullivan, 2021, bioRxiv.

Fc-mediated effector function contributes to the in vivo antiviral effect of an HIV neutralizing antibody

A. Perelson, J. Mascola, E. Boritz, 2020, Proceedings of the National Academy of Sciences.

Human Immunodeficiency Virus Type 1 Monoclonal Antibodies Suppress Acute Simian-Human Immunodeficiency Virus Viremia and Limit Seeding of Cell-Associated Viral Reservoirs

J. Mascola, R. Koup, J. Lifson, 2015, Journal of Virology.

Enhanced Potency of a Broadly Neutralizing HIV-1 Antibody In Vitro Improves Protection against Lentiviral Infection In Vivo

Young Do Kwon, Mario Roederer, Tongqing Zhou, 2014, Journal of Virology.

Enhanced neonatal Fc receptor function improves protection against primate SHIV infection

J. Mascola, A. Haase, G. Nabel, 2014, Nature.

mRNA-1273 Protects against SARS-CoV-2 Beta Infection in Nonhuman Primates

S. Elbashir, E. Boritz, D. Douek, 2021, Nature Immunology.

Evaluation of mRNA-1273 against SARS-CoV-2 B.1.351 Infection in Nonhuman Primates

S. Elbashir, D. Douek, N. Sullivan, 2021, bioRxiv.

Immune Correlates of Protection by mRNA-1273 Immunization against SARS-CoV-2 Infection in Nonhuman Primates

J. Mascola, D. Montefiori, D. Douek, 2021, bioRxiv.

Title: Immune Correlates of Protection by mRNA-1273 Immunization against 1 SARS-CoV-2 Infection in Nonhuman Primates

J. Mascola, D. Douek, N. Sullivan, 2021 .

Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1

J. Mascola, G. Chuang, M. Sastry, 2018, bioRxiv.

, In Vivo Infection Improves Protection against Lentiviral In Vitro Neutralizing HIV-1 Antibody Enhanced Potency of a Broadly

Kyle E. Roberts, Cinque S. Soto, B. Donald, 2014 .

Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in rhesus macaques coincides with anamnestic antibody response in the lung

J. Mascola, E. Boritz, D. Douek, 2021, Cell.

Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1

J. Mascola, Rui Chen, G. Chuang, 2018, Nature Medicine.

Immune Monitoring Reveals Fusion Peptide Priming to Imprint Cross-Clade HIV-Neutralizing Responses with a Characteristic Early B Cell Signature.

J. Mascola, G. Chuang, R. Koup, 2020, Cell reports.

mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits comparable B cell expansion, neutralizing antibodies and protection against Omicron

J. Mascola, D. Douek, N. Sullivan, 2022, bioRxiv.

mRNA-1273 or mRNA-Omicron boost in vaccinated macaques elicits similar B cell expansion, neutralizing responses, and protection from Omicron

J. Mascola, G. Chuang, D. Douek, 2022, Cell.

Potent Anti-Viral Activity of a Trispecific HIV Antibody in SHIV-Infected Monkeys

J. Mascola, R. Koup, J. Lifson, 2021, SSRN Electronic Journal.

Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4 receptor

J. Hoxie, J. Mascola, M. Connors, 2014, Science Translational Medicine.

Immunological and Virological Mechanisms of Vaccine-Mediated Protection Against SIV and HIV

Mario Roederer, Raphael Gottardo, Gary J. Nabel, 2013, Nature.

Distinct neutralizing antibody correlates of protection among related Zika virus vaccines identify a role for antibody quality

J. Mascola, A. Barrett, T. Pierson, 2020, Science Translational Medicine.

Immune and Genetic Correlates of Vaccine Protection Against Mucosal Infection by SIV in Monkeys

M. Hudgens, J. Mascola, D. Montefiori, 2011, Science Translational Medicine.

TRIM5 modulates penile mucosal acquisition of simian immunodeficiency virus in rhesus monkeys

B. Korber, P. Hraber, J. Mascola, 2011 .

The TRIM5 Gene Modulates Penile Mucosal Acquisition of Simian Immunodeficiency Virus in Rhesus Monkeys

B. Korber, P. Hraber, J. Mascola, 2011, Journal of Virology.

Protection against SARS-CoV-2 Beta variant in mRNA-1273 vaccine–boosted nonhuman primates

Chaim A. Schramm, J. Mascola, E. Boritz, 2021, Science.

RBD-based high affinity ACE2 antagonist limits SARS-CoV-2 replication in upper and lower airways

Y. Rudich, J. Zahradník, M. Roederer, 2023, bioRxiv.

Systems immunology of transcriptional responses to viral infection identifies conserved antiviral pathways across macaques and humans

P. Khatri, M. Roederer, C. Blish, 2023, bioRxiv.

Protection against SARS-CoV-2 Beta Variant in mRNA-1273 Boosted Nonhuman Primates

Chaim A. Schramm, J. Mascola, E. Boritz, 2021, bioRxiv.

Trispecific antibody targeting HIV-1 and T cells activates and eliminates latently-infected cells in HIV/SHIV infections

J. Mascola, M. Connors, R. Koup, 2023, Nature communications.

Epitope-based vaccine design yields fusion peptide-directed antibodies that neutralize diverse strains of HIV-1.

J. Mascola, G. Chuang, M. Sastry, 2018 .

Structure-based design of a single-chain triple-disulfide-stabilized fusion-glycoprotein trimer that elicits high-titer neutralizing responses against human metapneumovirus

J. Mascola, T. Zhou, P. Kwong, 2023, PLoS pathogens.

DNA Vaccination Elicits Protective Immune Responses against Pandemic and Classic Swine Influenza Viruses in Pigs

A. Vincent, G. Nabel, W. Kong, 2011, Clinical and Vaccine Immunology.

Immune and Genetic Correlates of Vaccine Protection Against Mucosal Infection by SIV in Monkeys

M. Hudgens, J. Mascola, D. Montefiori, 2011, Science Translational Medicine.

Enhanced Potency of a Broadly Neutralizing HIV-1 Antibody In Vitro Improves Protection against Lentiviral Infection In Vivo

Kyle E. Roberts, Cinque S. Soto, B. Donald, 2014, Journal of Virology.

Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4 receptor

J. Hoxie, J. Mascola, M. Connors, 2014, Science Translational Medicine.

Cholesterol reduction by immunization with a PCSK9 mimic.

J. Mascola, G. Chuang, Reda Rawi, 2024, Cell reports.

Cleavage-intermediate Lassa virus trimer elicits neutralizing responses, identifies neutralizing nanobodies, and reveals an apex-situated site-of-vulnerability

Chaim A. Schramm, J. Mascola, Chen-Hsiang Shen, 2024, Nature communications.